100 month survival of patients treated surgically for lung cancer: predictive value of magnetic resonance (MR) staging

A. H. Al-Ghamdi, J. R. Catterall, K. L. Bale, G. Laszlo, C. Forrester-Wood, P. Goddard (United Kingdom)

Source: Annual Congress 2002 - Oncology imaging: CT, MRI and PET
Session: Oncology imaging: CT, MRI and PET
Session type: Oral Presentation
Number: 3768
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. H. Al-Ghamdi, J. R. Catterall, K. L. Bale, G. Laszlo, C. Forrester-Wood, P. Goddard (United Kingdom). 100 month survival of patients treated surgically for lung cancer: predictive value of magnetic resonance (MR) staging. Eur Respir J 2002; 20: Suppl. 38, 3768

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007


Magnetic resonance imaging: a new possibility of lung cancer staging
Source: Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging
Year: 2009


Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007


Diffusion weighted MR can improve preoperative lung cancer diagnosis
Source: Annual Congress 2011 - Functional lung and pulmonary arterial imaging
Year: 2011

Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010

Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI)
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017

Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Multivolume proton-magnetic resonance imaging (1H-MRI) in lung transplant recipients: comparison with low dose computed tomography (CT).
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017

CT scans from CF patients screened for lung transplant; the severe advanced lung disease (SALD) CT scoring system and correlation with survival
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007




Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020


Five-year results of a feasibility study evaluating spiral computed tomography (sCT) for early detection of lung cancer (LC)
Source: Eur Respir J 2006; 28: Suppl. 50, 124s
Year: 2006

The use of perfusion SPECT imaging for preoperative evaluation of patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 38s
Year: 2002

A value of ultrasonographic predictors of malignancy in left adrenal gland in lung cancer patients – a comparison of EUS-b, CT and PET-CT
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021


Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




CT, PET or PETCT
Source: Annual Congress 2007 - Radiology Grand Round: an interactive session
Year: 2007

The surveillance of recurred/refractory lung malignancy using whole-body MRI: Correlation with the results assessed by PET-CT
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010

Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007